Skip to main content
logo
ReShape Lifesciences Inc. (RSLS)
Aug 15, 2025 - RSLS was delisted (reason: merged into HIND)
15.68
0.00 (0.00%)
Inactive · Last trade price on Aug 14, 2025

ReShape Lifesciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
113532920
Market Cap Growth
--31.25%42.48%-88.82%48.32%1073.04%
Enterprise Value
733-3328
Last Close Price
15.68446.001448.2639091.95475596.671029492.79

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
0.200.400.530.292.131.73
PB Ratio
1.76-12.560.690.890.651.35
P/TBV Ratio
1.81-0.690.951.23-

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
EV/Sales Ratio
1.010.330.40-0.242.48

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
0.02-3.820.040.050.010.92
Asset Turnover
0.841.040.800.350.300.30
Inventory Turnover
0.830.950.851.342.002.83
Quick Ratio
1.530.341.620.813.400.48
Current Ratio
2.770.922.731.333.980.77
Return on Equity (ROE)
-101.49%-222.47%-220.59%-192.58%-214.70%-112.09%
Return on Assets (ROA)
-53.96%-53.93%-83.92%-53.16%-34.82%-20.30%
Return on Invested Capital (ROIC)
-90.61%-109.11%-170.11%-69.87%-43.11%-27.20%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
-42.60%-224.34%-246.32%-1424.32%-217.66%-110.58%
FCF Yield
-72.09%-139.29%-367.80%-679.06%-54.21%-45.70%
SEC Filings: 10-K · 10-Q